Lannett Company, Inc. (NYSE Amex: LCI), a manufacturer of generic
pharmaceuticals, today announced that the company’s shares have been
added to the preliminary list of the Russell 2000® Index.
Russell indexes are widely used by investment managers and institutional
investors for both index funds and as benchmarks for passive and active
investment strategies. The Russell 2000 Index measures the performance
of the small-cap segment of the U.S. equity universe. The Index is
constructed to provide a comprehensive barometer of the broad market and
is reconstituted annually to include new and growing equities. The
reconstitution for the Russell 1000® Index, 2000®
Index and 3000® Index will be final on June 26 after the
close of the U.S. markets. Final membership lists will be posted on the
Russell Web site (www.russell.com)
on June 29.
“We are pleased with Lannett’s inclusion in the Russell index,” said
Arthur Bedrosian, president and chief executive officer. “Russell is an
industry leader for stock indexes, and we anticipate that our inclusion
will produce increased interest in our company.”
About Russell Investment Group
Russell offers investment planning services and diversified funds to
individual and institutional investors. Russell advises clients in 46
countries on the investment of approximately $786 billion in assets, and
serves approximately 600 organizations and thousands of individuals
through its investment management business. Today, $136.1 billion is
invested in Russell funds globally. For more information on Russell
indexes, go to www.russell.com.
About Lannett Company, Inc.
Lannett Company, founded in 1942, develops, manufactures, packages,
markets and distributes generic pharmaceutical products for a wide range
of indications. For more information, visit Lannett Company’s website at www.lannett.com.
PondelWilkinson Inc.
Robert Jaffe/Evan Pondel
310-279-5980
